Wave Life Sciences' alpha-1 antitrypsin deficiency candidate WVE-006 succeeded in the first-ever clinical demonstration of RNA editing in humans by achieving positive proof-of-mechanism in an ...
Among 198 patients with HIV who received a kidney from a deceased donor, risk of a safety event within a median of 2.2 years was similar between the two groups (adjusted HR 1.00, 95% CI 0.73-1.38), ...
Eight years ago, in what now seems like an act of reckless naivety, I bought my brother a 23andMe at-home DNA-test birthday present. Now the struggling company may sell its treasure trove of genetic ...